
Stereochemistry questions often look simple until one small detail changes the answer. You may know that a racemic mixture is 50:50, yet find it hard to explain why living systems use only one enantiomer. Questions on enantiomeric excess, R/S assignment and facial attack also mix calculation with concept, which makes them easy to get wrong under time pressure.
PW’s notes take this topic one idea at a time, moving from the 50:50 problem to catalyst selection, autocatalysis and Re/Si faces. You can use them to revise the concepts first and then test yourself on exam-style questions.
Naturally occurring amino acids are mostly L, and naturally occurring sugars are mostly D. This is surprising because a reaction that starts from an optically inactive compound can be attacked from either side. If both sides are equally likely, you get a racemic mixture, which contains both enantiomers in a 50:50 ratio.
The Kagan and Soai explanation shows how a small initial difference between enantiomers can gradually develop into a strong preference for one. This happens in two stages: first, a catalyst creates a slight excess of one enantiomer, which is then increased through autocatalysis.
A metal catalyst can combine with the different stereochemical forms present in a reaction. Three combinations are possible:
RR
SS
RS
The RS combination has cancelling optical effects, so it is optically inactive. In this model it is also taken to be unreactive, or much less reactive. As a result:
The RS form does not contribute effectively to product formation.
The RR and SS forms remain the active species.
The product no longer has the same enantiomeric ratio as the reactant.
Key point: the catalyst increases enantiomeric excess by making one type of combination unproductive.
Take a reactant that is 60% R and 40% S.
Enantiomeric excess (ee) = 60% − 40% = 20%
Now assume the molecules pair up at random:
RR = 0.60 × 0.60 = 0.36, or 36%
SS = 0.40 × 0.40 = 0.16, or 16%
RS = 2 × 0.60 × 0.40 = 0.48, or 48%, which is unavailable for reaction
Only 36% + 16% = 52% remains active, so:
ee of product = (36 − 16) / 52 × 100, which is approximately 38%
The ee rises from 20% in the reactant to about 38% in the product. This is called a nonlinear effect, because the product’s ee is not in simple proportion to the reactant’s ee.
Memory tip: remove the inactive RS portion first, then calculate the ee from RR and SS only.
Want to practise enantiomeric excess and isomer-based questions? Attempt PW’s Isomerism MCQs for JEE Main and Advanced.
Autocatalysis means that a product helps to make more of itself. In the Soai reaction, pyrimidine-5-carbaldehyde reacts with diisopropylzinc. The process runs like this:
A small amount of one enantiomer, say S, forms first.
This S product promotes the formation of more S product.
With repeated cycles, the initial ee is amplified.
The product can reach about 99% S.
So a very small starting imbalance does not stay small. This is a possible explanation for how one enantiomer came to dominate in nature.
Before the reaction, the carbonyl carbon is sp2 hybridised and is not a chiral centre. A nucleophile can attack from either face of the planar C=O group. After the attack, the carbon becomes sp3, and if its four groups are different, a new chiral centre forms. This is the same carbonyl reactivity you meet in aldehydes and ketones, where nucleophilic addition is the key reaction.
The two faces are named using the Cahn–Ingold–Prelog (CIP) priority rules. To brush up on assigning priorities, revise PW’s [R and S configuration notes – link].
Re face: the groups appear clockwise in order of CIP priority, and the face is associated with R.
Si face: the groups appear anticlockwise in order of CIP priority, and the face is associated with S.
In the example used in the notes, the priorities on the viewed face are oxygen, then the ethyl group, then the methyl group. The face label describes the face itself. The final R or S label of the product also depends on the priority of the incoming group. Attack on different faces gives different configurations.
Once the S product has formed, its oxygen and zinc atoms can hold the next substrate molecule in a fixed position. The substrate is held from the back, so the incoming propyl-type group can approach only from the front. This favours the S configuration, so the first S product guides the formation of more S.
Memory tip: Re is clockwise and R-type, and Si is anticlockwise and S-type. In autocatalysis, the first-formed enantiomer promotes more of itself.
Find Re and Si faces easier to follow when a teacher explains them step by step? Learn with PW’s
The two ideas work one after the other:
The catalyst removes some combinations (RS) from productive reaction.
The remaining RR and SS species create an initial imbalance.
Autocatalysis amplifies this imbalance.
Repeated cycles make one enantiomer strongly dominant.
This is a possible explanation for why L-amino acids and D-sugars dominate in living systems. If you want to see where these molecules fit in the bigger picture, go through Biomolecules JEE notes.
Want a quick visual revision of L-amino acids and D-sugars? Download PW’s Biomolecules JEE mind maps.
Enantiomers of the same drug can interact differently with the body, so they may differ in effect, side effects or activity. That is why single-enantiomer drugs matter in pharmaceutical chemistry.
Cetirizine and levocetirizine: cetirizine exists as two enantiomers, the D (R) and L (S) forms. Levocetirizine is useful for controlling a runny nose and allergic nasal symptoms, while the other enantiomer was associated with sedation. The less desirable form was separated out, and levocetirizine is the form available in the market.
Salbutamol and levosalbutamol: salbutamol is also chiral, and levosalbutamol is the therapeutically preferred form.
These examples show why preparing or separating the useful enantiomer is important.
PW notes explain how a catalyst creates an initial preference for one enantiomer, which is then amplified through autocatalysis. The notes also cover Re and Si face attacks, showing how they lead to different configurations and help explain the role of chirality in drugs.
|
Resource Name |
Link |
|
JEE Syllabus |
|
|
JEE PYQs |
|
|
JEE Sample Paper |
|
|
JEE Main Formulas |
|
|
JEE Advanced Formulas |
|
|
JEE Advanced Sample Paper |
|
|
JEE Advanced PYQs |